ADVM-022 clinical trials

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

This study, called LUNA, is testing a new gene therapy called ADVM-022 for 'wet' Age-related Macular Degeneration (nAMD). It aims to reduce the need for frequent eye injections by delivering a sustained treatment with a single injection, hoping to improve vision. We're looking at its safety and how well it works.